Endocrinology News and Research

Latest Endocrinology News and Research

Exercise could reduce metabolic disease complications in patients post-transplantation

New research reveals that metabolic syndrome—risk factors that can lead to heart disease and/or stroke—is common in liver transplant recipients, with rates highest at one year following the procedure.

7 Aug 2013

Strathclyde team develops new type of Raman laser that harnesses diamonds to produce light beams

Ground-breaking research is harnessing the unique properties of diamonds to develop a new generation of lasers that could lead to many benefits, from better treatment of skin complaints and diabetes-related eye conditions to improved pollution monitoring and aeronautical engineering

7 Aug 2013

Exercise could help reduce metabolic syndrome problems in liver transplant recipients

New research reveals that metabolic syndrome-risk factors that can lead to heart disease and/or stroke-is common in liver transplant recipients, with rates highest at one year following the procedure.

7 Aug 2013

Personalized models for preventive health care services

With physicians facing increasing demands on their time, it can be extremely difficult to prioritize which preventive care methods should be used for their patients. Now, two researchers at NYU Langone Medical Center have developed a mathematical model that will save time, lead to enhanced care, and potentially save lives.

6 Aug 2013

Research links high prevalence of Type 2 diabetes in the American South with economic conditions

The strikingly high prevalence of Type 2 diabetes in the American South can be partially traced to rapid economic growth between 1950 and 1980, new research suggests.

6 Aug 2013

Regeneron, Bayer report positive results from Phase 3 VIVID-DME and VISTA-DME trials of EYLEA for DME

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that in the Phase 3 VIVID-DME and VISTA-DME trials of EYLEA (aflibercept) Injection for the treatment of diabetic macular edema, EYLEA 2 milligrams (mg) dosed monthly and EYLEA 2 mg dosed every two months (after 5 initial monthly injections) achieved the primary endpoint of a significantly greater improvement in best-corrected visual acuity from baseline compared to laser photocoagulation at 52 weeks.

6 Aug 2013

NIH-funded study of aquaporin proteins could hold clues to cataract

Researchers have achieved dynamic, atomic-scale views of a protein needed to maintain the transparency of the lens in the human eye. The work, funded in part by the National Institutes of Health, could lead to new insights and drugs for treating cataract and a variety of other health conditions.

6 Aug 2013

Study reveals nearly 40% of tumors are caused by viruses

The results of a large-scale analysis of the association between DNA viruses and human malignancies suggest that many of the most common cancers are not associated with DNA viruses.

6 Aug 2013

People who walk to work are less likely to have diabetes and high blood pressure

People who walk to work are around 40 per cent less likely to have diabetes as those who drive, according to a new study.

6 Aug 2013

Mothers who breastfeed may have lower risk of Alzheimer's

The report, newly published in the Journal of Alzheimer's Disease, suggests that the link may be to do with certain biological effects of breastfeeding. For example, breastfeeding restores insulin tolerance which is significantly reduced during pregnancy, and Alzheimer's is characterised by insulin resistance in the brain.

6 Aug 2013

New effort could dramatically improve surgical outcomes in children, say surgeons

A group of pediatric surgeons at hospitals around the country have designed a system to collect and analyze data on surgical outcomes in children - the National Surgical Quality Improvement Program (NSQIP) is the first national database able to reliably compare outcomes among different hospitals where children's surgery is performed.

6 Aug 2013

High-calorie breakfast protects against diabetes, hypertension and cardiovascular problems

Whether you hope to lose weight or just stay healthy, what you eat is a crucial factor. The right nutrients can not only trim your waistline, but also provide energy, improve your mood, and stave off disease. Now a Tel Aviv University researcher has found that it's not just what you eat - but when.

6 Aug 2013

Obese white Americans are twice as likely as blacks to have bariatric surgery

White Americans who are obese are twice as likely as black Americans to have surgery to tackle the problem, a study has found.

5 Aug 2013

Prospective health of the Hispanic/Latino population in the US: an interview with Dr. Martha Daviglus, University of Illinois at Chicago

Heart disease is one of the leading causes of death among Hispanic/ Latino adults living in the US and this population is known to have high rates of obesity and diabetes.

5 Aug 2013

Sleeping patterns of baby birds are similar to that of baby humans, find researchers

Researchers at the Max Planck Institute for Ornithology and the University of Lausanne have discovered that the sleeping patterns of baby birds are similar to that of baby mammals. What is more, the sleep of baby birds appears to change in the same way as it does in humans.

5 Aug 2013

Clot-inhibiting drug apixaban shows added benefits in adults with non-valvular atrial fibrillation

The clot-inhibiting drug apixaban (trade name: Eliquis) has been approved in Germany since November 2012 for the prevention of embolism and stroke in adults with non-valvular atrial fibrillation.

3 Aug 2013

IQWiG dossier assessment finds no added benefit of lixisenatide

Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care examined whether this new drug offers an added benefit over the current standard therapy.

3 Aug 2013

Added benefit of thyroid cancer drug vandetanib not proven

Vandetanib (trade name: Caprelsa) has been approved in Germany since February 2012 for the treatment of adult patients who have a particular form of aggressive thyroid cancer. In a new benefit assessment, the German Institute for Quality and Efficiency in Health Care has now examined the added benefit of the drug pursuant to the Act on the Reform of the Market for Medicinal Products.

3 Aug 2013

Build-up of harmful chemicals in the body affects people of all social standings

A new study published this week has found that the build-up of harmful chemicals in the body is affecting people of all social standings -- not just those from economically deprived backgrounds as previously thought.

2 Aug 2013

Researchers now have more complete picture of mTORC1 pathway that can lead to cancer, diabetes

Deciphering the body's complex molecular pathways that lead to disease when they malfunction is highly challenging. Researchers at Sanford-Burnham Medical Research Institute now have a more complete picture of one particular pathway that can lead to cancer and diabetes. In the study published by Molecular Cell, the scientists uncovered how a protein called p62 has a cascade affect in regulating cell growth in response to the presence of nutrients such as amino acids and glucose. Disrupting this chain may offer a new approach to treating disease.

2 Aug 2013

Endocrinology News and Research

Latest Endocrinology News and Research

Exercise could reduce metabolic disease complications in patients post-transplantation

Strathclyde team develops new type of Raman laser that harnesses diamonds to produce light beams

Exercise could help reduce metabolic syndrome problems in liver transplant recipients

Personalized models for preventive health care services

Research links high prevalence of Type 2 diabetes in the American South with economic conditions

Regeneron, Bayer report positive results from Phase 3 VIVID-DME and VISTA-DME trials of EYLEA for DME

NIH-funded study of aquaporin proteins could hold clues to cataract

Study reveals nearly 40% of tumors are caused by viruses

People who walk to work are less likely to have diabetes and high blood pressure

Mothers who breastfeed may have lower risk of Alzheimer's

New effort could dramatically improve surgical outcomes in children, say surgeons

High-calorie breakfast protects against diabetes, hypertension and cardiovascular problems

Obese white Americans are twice as likely as blacks to have bariatric surgery

Prospective health of the Hispanic/Latino population in the US: an interview with Dr. Martha Daviglus, University of Illinois at Chicago

Sleeping patterns of baby birds are similar to that of baby humans, find researchers

Clot-inhibiting drug apixaban shows added benefits in adults with non-valvular atrial fibrillation

IQWiG dossier assessment finds no added benefit of lixisenatide

Added benefit of thyroid cancer drug vandetanib not proven

Build-up of harmful chemicals in the body affects people of all social standings

Researchers now have more complete picture of mTORC1 pathway that can lead to cancer, diabetes

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Endocrinology News and Research

Latest Endocrinology News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in